Rapport Therapeutics, Inc. (RAPP)
Follow Rapport Therapeutics, Inc. (RAPP) for new congressional filings and notable company-insider purchases. No congressional trades are visible in this view.
- Trades disclosed
- 0
- Members trading
- 0
- Buys / sells
- 0 / 0
- Reported value
- Undisclosed
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at RAPP
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
RAPP: HEALY JAMES reported buying shares
4 reported purchases of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
RAPP: Sanchez Ramiro reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
RAPP: Silva Paul M reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
RAPP: Young Wendy B. reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
RAPP: PAUL STEVEN M reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
All trades
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.